Trial Profile
To Assess the Pharmacokinetics and Pharmacodynamics of IN-105 in Relation to the Pre-meal Dosing Time, Between-meal Interval and Type of Meal - A Phase 1, Three Cohort, Randomized, Placebo Controlled, Crossover Trial in Type 2 Diabetes Patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jul 2018
Price :
$35
*
At a glance
- Drugs Insulin tregopil (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Biocon
- 26 Jun 2018 Results (cohort 2; n=18) presented at the 78th Annual Scientific Sessions of the American Diabetes Association.
- 26 Jun 2018 Results (cohort 1; n=15) presented at the 78th Annual Scientific Sessions of the American Diabetes Association
- 10 Jan 2018 New trial record